
Please try another search
Geron Corporation, a commercial-stage biopharmaceutical company, focuses on the development of therapeutics products for oncology. It offers RYTELO a telomerase inhibitor for the treatment f adult patients with low- to intermediate-1 risk myelodysplastic syndromes with transfusion-dependent anemia. The company was incorporated in 1990 and is headquartered in Foster City, California.
Name | Age | Since | Title |
---|---|---|---|
Dawn Carter Bir | 54 | 2019 | Interim President & Chief Executive Officer and Director |
Susan M. Molineaux | 71 | 2012 | Independent Director |
V. Bryan Lawlis | 73 | 2012 | Independent Director |
Robert Jay Spiegel | 76 | 2010 | Independent Director |
Elizabeth A. O'Farrell | 59 | 2019 | Lead Independent Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review